Cell-free synthetic biochemistry provides a green solution to replace traditional 23 petroleum or agricultural based methods for production of fine chemicals. 4-(4-24 hydroxyphenyl)-butan-2-one, also known as raspberry ketone, is the major fragrance 25 component of raspberry fruit and is utilised as a natural additive in the food and 26 sports industry. Current industrial processing standards involve chemical extraction 27 with a yield of 1-4 mg per kilo of fruit. As such its market price can fluctuate up to 28 $20,000 per kg. Metabolic engineering approaches to synthesise this molecule by 29 microbial fermentation have only resulted in low yields of up to 5 mg L -1 . In contrast, 30 cell-free synthetic biochemistry offers an intriguing compromise to the engineering 31 constraints provided by the living cell. Using purified enzymes or a two-step semi-32 synthetic route, an optimised pathway was formed for raspberry ketone synthesis 33 leading up to 100% yield conversion. The semi-synthetic route is potentially scalable 34 and cost-efficient for industrial synthesis of raspberry ketone. 35 36 ketone (from 0.2 to 5 mg L -1 ), even despite the use of high cell-density fermentation. 55
Introduction 37
For fine chemical biomanufacturing, synthetic biology aims to provide green 38 solutions to replacing traditional petroleum or arable farming based production 39 methods 1-6 . The synthetic biochemistry approach, whereby metabolic pathways can 40 be entirely reconstituted within a test-tube with purified enzymes 7-11 or cell-free 41 extracts 12-14 , offers a realistic concept to traditional cell based engineering, with the 42 potential for high performance synthesis of fine chemicals and recombinant proteins 43 to the industrial scale 11, 15 . 44 45 4-(4-hydroxyphenyl)butan-2-one, commonly referred to as raspberry ketone, is the 46 major fragrance compound from raspberry berries (Rubeus rubrum). Raspberry 47 ketone is harvested by chemical extraction at a ratio of 1-4 mg per kilo of fruit 16 . This 48 presents a highly-inefficient purification process, which is reflected by a high market 49
price for naturally extracted raspberry ketone that fluctuates at approximately 50 $10,000-20,000 kg -1 , with global production estimated at between 100-200 tons per 51 annum 16, 17 . As an alternative green solution for its production, raspberry ketone can 52 be synthesised in microbial cells. However, current efforts in either Escherichia coli 17 53 or Saccharomyces cerevisiae 17,18 have only produced limited quantities of raspberry 54 with the rationale that a delicate balance of these is likely necessary to maximise 146 total production concentration because they both rely on CoA for their synthesis. 147 148
Previously, curcumin, which is a structural dimer of raspberry ketone, was identified 149 to exhibit fluorescence when bound non-specifically to Gram-negative bacterial 150 extracellular curli (amyloid-type) protein fibres 39 . The precursor of curcumin, 151 bidesmethoxycurcumin (BDMC), is synthesised from p-coumoroyl-CoA and malonyl-152
CoA by the curcumin synthase (CUS) 40 , a type III polyketide synthase that is related 153 to the BAS enzyme with 69% amino acid identity. Additionally, a NADPH-dependent 154 curcumin double bond reductase (CurA), which is related to the RKS reductase 155 enzyme with 38% amino acid identity, was previously characterised from E. coli 41 
. A 156
Phyre2 42 structural model of CurA suggested a large active site dominated by Tyr 157
and Phe residues. Based on the potential fluorescence properties of non-specifically 158 bound curcumin, we speculated that substrate binding of the apo-form of CurA to 159 either curcumin or BDMC would also generate fluorescence through p-p stacking 160 within the aromatic active site. To test this, we overexpressed and purified CurA with 161 an N-terminal His 6 -tag from E. coli BL21 Gold (DE3) pLysS. Mixing an equal amount 162 (10 µM) of apo-CurA with curcumin resulted in strong fluorescence with a maximum 163 excitation and emission peaks at 425 nm and 520 nm, respectively, indicating ligand 164 binding (Supplementary Figure S2 ). If an excess (100 µM) of NADPH was also 165 added, the yellow coloured curcumin was rapidly reduced into the colourless 166 tetrahydrocurcumin. This resulted in a quenching of the fluorescence, due to double 167 bond reduction and a loss of conjugation. This suggested that CurA could bind 168 curcumin in the absence of NADPH and therefore does not require the formation of a 169 ternary complex. Next, with 25 µM of CurA incubated with an increasing concentration of curcumin (0-100 µM), the fluorescence signal fitted an exponential 171 saturation curve (Supplementary Figure S3 ). Further increases in signal could be 172 achieved with higher levels of CurA protein, but since the yield of recombinant CurA 173 in E. coli was limiting (~10 mg L -1 ), a maximum level of 25 µM was used for 174 subsequent assays to preserve protein stocks.
176
To confirm the use of this protein-ligand sensor as a real-time fluorescence assay of 177 BDMC/curcumin synthesis, 25 µM of CurA was mixed in a one-pot reaction 178 containing 1 µM of TAL, PCL, MatB and the type III polyketide synthase, CUS, along 179 with the necessary cofactors and 1 mM Tyrosine. In addition, each enzyme was 180 individually omitted as a control to confirm the specificity of the assay. Following a 181 time-course reaction, an increasing fluorescence signal was observed 182 (Supplementary Figure S4 ), relative to a stable background signal if any of the 183 enzymes or substrates were omitted (Supplementary Figure S4 ). The initial rate of 184 the fluorescence signal was further improved by increasing the concentration of the 185 substrate tyrosine or the CUS enzyme (Supplementary Figure  S5 ). Furthermore, if a 186 1 µM aliquot of NADPH was injected midway through the reaction, a reduced 187 fluorescence was observed, confirming that reduction of the double bond quenches 188 the fluorescence. This confirmed the sensitivity and specificity of the assay for 189 BDMC synthesis. 190 191
Optimising the synthesis the substrates p-coumoryl-CoA and malonyl-CoA 192
To potentially improve the activity of the BAS enzyme, we next sought to use our 193 novel fluorescence small molecule sensor to rapidly optimise the synthesis of the 194 substrates p-coumoryl-CoA and malonyl-CoA in vitro. Firstly, one-pot synthesis of BDMC accumulated a yellow visual appearance ( Figure  2C ), which was fluorescent 196
in the presence of the CurA sensor ( Figure 2D ). Initially, the conditions for in vitro 197 synthesis of BDMC were optimised. Firstly, tyrosine and CUS levels were set at 5 198 mM and 25 µM, respectively, so that these parameters were not rate limiting 199 (Supplementary Figure  S5 ). An important consideration for in vitro enzyme systems 200 is the concentration of substrates and cofactors ( Figure 2B ). BDMC synthesis was 201 next optimised with respect to ATP, Mg 2+ , CoA and malonate levels. As expected, 202 the ATP level was critical to BDMC synthesis with at least 1 mM required to reach 203 fluorescence saturation (~65,000 RFU), whilst for optimal malonyl-CoA supply, a 204 concentration of greater than 2.5 mM malonate was required for maximal activity 205 (>60,000 RFU) and fluorescence saturation. The Mg 2+ levels were equally optimal at 206 0.1-1 mM, but with higher levels, a biphasic fluorescence curve was observed 207 ( Figure 2B ). A similar observation also occurred with the levels of CoA, where 208 concentrations below the optimum level (0.25 mM) were also found to demonstrate a 209 biphasic response. One potential interpretation of this response is a temporary 210 depletion of free CoA availability, thus leading to an imbalance between p-coumoryl-211
CoA and malonyl-CoA levels for the CUS enzyme. In contrast, if higher levels of CoA 212 (>1 mM) were added, complete inhibition of CurA-BDMC was observed ( Figure  2B ).
214
We next used this optimised set of conditions to determine if the enzyme levels of 215 TAL, PCL or MatB control BDMC synthesis. To do this, each enzyme was varied in a 216 4-fold dilution series from 0.0156 to 16 µM. Firstly, some background fluorescence 217 attributed to high levels of p-coumoryl-CoA occurred if the level of the PCL enzyme 218 was increased above 1 µM ( Figure  2E ). However, if both the levels of the TAL and 219 PCL enzymes were optimised to a peak concentration of 16 µM and 1 µM, 220 respectively, maximal BDMC synthesis (87,400 RFU) was reached. Interestingly, by 221 varying PCL and MatB together, noticeably a careful balance of enzymes was 222 required to prevent pathway inhibition, possibly through depletion of free CoA (Figure  223 2D). This evidence overall suggests that the pathway is tightly regulated by a 224 sensitive interplay between the free CoA pool, CoA derivatives, CoA-dependent 225 enzymes and the rate-limiting activity of the type III polyketide synthase (CUS). 226
Therefore, whilst this experiment only provides a relative measure of pathway 227 activity, it demonstrates that a finely tuned interplay between enzyme levels and the 228
CoA cofactor is required for optimal pathway performance. This observation would 229 not be possible to detect through cell-based engineering. Based on these 230 measurements, we next used the optimal parameters to determine whether 231 raspberry ketone synthesis could be improved. 232 233
Raspberry ketone biosynthesis is inhibited by a high tyrosine concentration 234
We next sought to increase the yield of raspberry ketone synthesis in vitro by 235 providing optimised levels of p-coumoroyl-CoA and malonyl-CoA synthesis using the 236 parameters determined in CurA-BDMC fluorescence assay. Firstly, batch reactions 237 were prepared with varying concentrations of tyrosine from 100-1000 µM. Between 238 100-300 µM tyrosine, raspberry ketone was produced at a 100% yield ( Figure 3A) . 239
Beyond this, the level of p-coumarate rises, without a further increase in raspberry 240 ketone yield. Initially, we suspected that the supply of malonyl-CoA or p-coumoryl-241
CoA was limited by the exhaustion of the ATP supply. However, although providing 242 ATP regeneration through phosphoenolpyruvate (PEP) and pyruvate kinase 243 increased the flux of tyrosine and p-coumarate, the net yield of raspberry ketone was 244 lowered ( Figure 3B ). Unexpectedly, these conditions led to an accumulation (~30-245 50%) of the BAS catalysed side-product bisnoryanogonin (BNY), in comparison to 246 standard conditions where only minor levels (~5%) were detected by LC-MS. BNY is 247 a side-product of the BAS enzyme that is produced by an additional malonyl-CoA 248 extension of the diketide intermediate 43 . Previously, BNY was produced only at 249 minor levels at mildly alkaline pH (7.5-8.5), but elevated at pH 6.0-7.5 in Tris-HCl or 250 phosphate buffers 43 . To attempt to correct this issue, we repeated the synthesis of 251 raspberry ketone in a range of alkaline buffers (pH 7.5-9.0) and as a time-course at 252 pH 9 (Supplementary Figure S7 ). Increasing the pH favoured the activities of the 253 TAL and PCL enzymes, but this did not further increase the levels of raspberry 254 ketone and only a minor decrease in the levels of the BNY side-product was 255
observed. Under these forced synthetic conditions, it appears that the HBA synthesis 256 activity of the BAS enzyme switches towards a preference of BNY synthesis. Since 257 we could not find a route to eliminate BNY synthesis and this capped our overall 258 yield of raspberry ketone, we next considered how the cost-efficiency of this in vitro 259 pathway could be improved by relaxing the cofactor specificity of the NADPH-260 dependent RKS reductase step. 261 262
NADH is rate limiting for in vitro raspberry ketone synthesis 263
The final step of raspberry ketone synthesis is catalysed by the NADPH-dependent 264 double bond reductase RKS. For in vitro based biocatalysis, NADH 44 or biomimetic 265 analogues 45 are preferred to provide increased stability and reduced cost for 266 reductive enzyme reactions. We therefore revisited the one-pot synthesis of 267 raspberry ketone providing NADH, as opposed to NADPH, as a cofactor 268 (Supplementary Figure  S6 Figure S8 ). For all further RKS enzyme assays, these 286 were measured at 30°C and pH 6.4, with 1 mM of phenylbuten-2-one. Under these 287 conditions, RKS shows an apparent K cat /K m of 58 and 1.3 mM s -1 mM -1 with NADPH 288 and NADH, respectively ( Supplementary Table S3 ). This demonstrates a 45-fold 289 preference for NADPH as a cofactor. 290 291
Structure guided engineering of a NADH proficient RKS 292
A number of studies have highlighted that the cofactor specificity of NADPH-293 dependent reductase enzymes can be relaxed towards NADH utilisation 47-50 by 294 modulating the interaction of the enzyme from the ribose 5'-phosphate (NADPH) in 295 preference to the ribose 5'-hydroxyl group (NADH) 51,52 . To aid in the rational design 296 of increasing NADH activity of the RKS enzyme, we crystallised and solved the 297 tertiary structure complex of RKS with raspberry ketone pathway substrate HBA 298 ( Figure 4A ) and the cofactor NADPH ( Figure 4B ), deposited as pdb: 6EOW. By 299 analysing the 2F 0 - F c Fourier syntheses, two configuration states were observed at 300 a 50:50 ratio due to crystal soaking. The mixed states could be as a result of NADPH 301 and ternary complex formation to the active site, thus displacing any NADP + present 302 from crystallisation. In the ternary complex state, additional electron density for HBA 303 binding is observed, with p-p stacking between the HBA and nicotinamide aromatic 304 rings ( Figure 4A provided by a triad of hydrogen bond based contacts with the G191 backbone 317 nitrogen and the side chains K195 and Y211 ( Figure 4B ). Whilst K212 is also 318 present, it is rather removed from binding to the ribose 5'-phosphate. Importantly, K195 can interact with either the ribose 5'-phosphate or neighbouring 4'-hydroxyl 320 group.
322
In an effort to modify the cofactor specificity of the RKS enzyme, a number of amino 323 acid substitutions at G191 and Y211 were made and steady-state kinetics was 324 determined where appropriate ( Figure  4C and Supplementary  Table  S3 ). We did not 325 attempt to modify K195 due to its role in bonding to the 4' hydroxyl group found in 326 both NADPH and NADH. We instead chose to modify G191 to provide a short polar 327 side chain (D and N) that can provide a hydrogen bond for the 5'-hydroxyl group 328 unique to NADH. Both the D191 and N191 modifications decreased the k cat /K m from 329 58 mM -1 s -1 (RKS WT ) with NADPH to 14 and 15 (s -1 mM -1 ), respectively ( Figure  4C ). 330
This decrease in catalytic efficiency was due to an increased K m for NADPH with the 331 variants. Interestingly, for N191, the k cat increased by 3-fold up to 1.07 s -1 in 332 comparison to the wild-type (0.31 s -1 ). One possible interpretation is that steric 333 hindrance of N191 with the 5' phosphate increases the catalytic rate by enhancing 334 NADP + release through decreasing its binding affinity. In contrast, with NADH as the 335 cofactor, whilst N191 did not improve NADH utilisation, D191 was found to increase 336 the k cat /K m from 1.3 mM -1 s -1 (RKS WT ) to 5.9 mM -1 s -1 ( Figure  4D and Supplementary 337 Table S3 ). In summary, these mutagenesis experiments at the G191 position 338 demonstrated that the negatively charged (D) side chain improves NADH specificity 339 in preference to a positive charged residue (N). Whilst further modifications to the 340 Y211 position were also tested individually or in combination with D191 and N191 341 (data not shown), no further improvements in NADH specificity or k cat were found, 342 with most modifications leading to a loss of activity with either NADH or NADPH.
344
Whilst the kinetics of RKS (wild-type and D191) were not characterised with its 346 natural substrate, HBA, its activity was demonstrated with NAD(P)H cofactor 347 regeneration. Firstly, HBA was synthesised from the inexpensive substrates p-348 benzaldehyde ($203 per kg) and acetic acid ($67 per kg) using an aldol 349 condensation reaction under basic conditions to provide a 76% yield 54 ( Figure  5A) . Table S2 ). In comparison, for RKS D191 , the rates of reduction with 362 NADPH and NADH were nearly equivalent at 46.5 and 43.5 µM/min/mg, respectively 363 ( Supplementary Table S2 ). This demonstrated high-yield and efficient synthesis of 364 raspberry ketone with the RKS D191 variant providing an elevated and complete 365 turnover (~100%) with the inexpensive NADH cofactor. RKS reductase activity was 366 also stable for several days at room temperature (data not shown). 367 368
NADH based in vitro synthesis of raspberry ketone from tyrosine 369
To understand whether the RKS D191 variant could be used for in vitro synthesis of 370 raspberry ketone with NADH, three time-course reactions were prepared with 1 mM 371 tyrosine and optimised enzyme levels and cofactors with either an absence of the 372 reductase or a combination of RKS WT /NADPH or RKS D191 /NADH. Firstly, ATP 373 regeneration was omitted to limit the accumulation of the BNY intermediate. Then, 374 without the RKS reductase, the reaction accumulated HBA at a rate of 0.81 µM min -1 375
( Supplementary  Table  S2 Figure  6B ).
Discussion 388
Synthetic biochemistry offers an exciting opportunity to design and engineer enzyme 389 pathways outside of the constraints of a living cell. Recent advances include the 390 generation of a synthetic CO 2 fixation cycle 56 and the potential industrial scale 391 synthesis of bioplastic 11 . Here, we show the application of the synthetic biochemistry 392 approach to the synthesis of the natural product raspberry ketone. There is 393 increasing interest in natural product biosynthesis as a source of new antimicrobials, 394 human therapeutics, and fine chemicals. The synthetic biochemistry platform, which 395 allows the rapid optimisation of pathway flux 12,57 using purified enzymes from 396 different sources to identify high yielding combinations, is a powerful tool for natural 397 product biosynthesis. Potentially, it could be used as a drug discovery tool, e.g. for 398
probing the function of newly identified gene clusters in a sequential manner that 399 allows the documentation of individual enzyme activities.
401
Natural products and other high-value fine chemicals are often only synthesized at 402 very low concentrations in their natural source. Unless chemical logic (i.e reactive 403 species) dictates, metabolic pathway enzymes lack selective pressure to evolve 404 enhanced catalytic rates. For raspberry ketone, only tiny quantities are synthesised 405 in the berries themselves and the process requires weeks of maturation. Therefore, 406 yields as low as 1-4 mg per kilo of raspberry are obtained by chemical extraction of 407 natural raspberry ketone fragrance 17 . To meet the demand of raspberry ketone for 408 the food and sports industry, a two-step organic synthesis via an aldol condensation 409 followed by a rhodium-catalysed hydrogenation reaction is used 58 . However, there is 410 interest in developing a greener approach using synthetic biology to obtain this 411 natural product. Previous work has investigated synthetically engineered E. coli 17 412 and Baker's Yeast 17,18 systems, but yields from fermentation have been limited. 413 414
One of the advantages of the synthetic biochemistry approach is the ability to 415 produce compounds that are toxic to cells or require high levels of enzyme 416 expression to overcome pathway bottlenecks, which can lead to metabolic burden in 417 vivo. Processes can also be designed to convert central metabolites to products 418 without syphoning off essential resources required for cellular growth. Metabolic 419 engineering in vivo requires a delicate balance between flux towards the product and 420 towards biomass accumulation. When flux towards the product is sufficiently high to 421 reduce cellular growth rates, there is inherent evolutionary pressure to lower 422 productivity because mutations that reduce enzyme expression or primary metabolite 423 usage will lead to a selective advantage. Our synthetic biochemistry platform utilises 424 purified proteins in vitro and therefore is not subject to evolutionary pressure to 425 decrease productivity. In principle, any compound can be produced from any starting 426 material without incurring metabolic burden. Synthetic biochemistry can, therefore, 427 be considered 'evolution-free' and often results in higher yields of product than can 428 be achieved via in vivo production. In our case, we obtained 61 mg L -1 raspberry 429 ketone in a batch system, which is approximately 10-fold higher than the highest 430 reported concentration from fermentation. Further improvement could also be 431 achieved with a continuous flow system such as that reported recently by Hold et al 432 57 for active provision of substrates and removal of product. Moreover, during our 433 optimisation experiments, we identified that high concentrations of tyrosine as the 434 starting substrate inhibited the overall yield of raspberry ketone. Our study hints that 435 there may be a novel regulation mechanism of the BAS enzyme, possibly allosteric, 436 that prevents over-accumulation of raspberry ketone in its native host. Therefore, 437 synthetic biochemistry can also be a powerful tool for research as well as production 438 of compounds. 439 440
Another advantage of the synthetic biochemistry platform is the ability to combine 441 enzymes from different sources with greater ease and less metabolic burden than 442 constructing a strain expressing the whole heterologous pathway. Although we 443 chose to express our enzymes in E. coli, in principle pathway variants that are 444 'difficult-to-express' or require post-translational modifications can be expressed and 445 purified in another host, but still mixed with an inexpensive cell-lysate derived from E. 446 coli to provide energy metabolism to drive the reaction phase. This hybrid approach 447 is not possible with in vivo metabolic engineering where a single production chassis 448 is chosen and its choice may constrain the expression levels of the heterologous 449 pathway or the choice of enzyme source.
451
Raspberry ketone, although one of the simpler polyketides, still has a complicated 452 biosynthetic pathway that requires ATP, malonyl-coA, and NAD(P)H as cofactors. 453
We showed that each of these could be recycled in situ through the application of 454 appropriate cofactor regeneration schemes, but that this must be balanced to avoid 455 the accumulation of side products. In addition, we found that the relative levels of 456 malonyl-CoA, p-coumoryl-CoA, and free CoA are a key consideration for maximising 457 yield. The use of an in vitro platform allows precise molecular control over the 458 concentration of enzymes, which would be difficult to achieve in vivo with the 459 currently available gene expression tools. 460 461 462
To achieve a fine-tuned in vitro performance, we have also developed a novel 463 protein-ligand binding fluorescence sensor for direct detection of polyketide 464 synthesis activity and used it to maximise the accumulation of the common 465 intermediates of the raspberry ketone and curcumin biosynthesis pathways. This 466 method could be extended for optimisation of biosynthesis of related polyketides or 467 increase flux towards the malonyl-CoA pool in vivo, but will require the inactivation of 468 the CurA reductase activity through point mutations. Given the structural 469 conservation of reductase enzymes, a similar strategy could also be used to develop 470 biosensors for other polyketides in the benzylaklaloid family or to screen variants of 471 the TAL, PCL, or MatB enzymes in order to further increase the yields of raspberry 472 ketone in our synthetic biochemistry platform.
474
We also demonstrated that raspberry ketone can be synthesised from either tyrosine 475 (the natural substrate in vivo), or through a hybrid chemoenzymatic process where 476
HBA is synthesised in one chemical synthesis step, followed by enzymatic 477 conversion to raspberry ketone. p-coumarate is also an abundant renewable 478 substrate that can be derived from lignin, so is another plausible starting substrate. 479
The chemoenzymatic approach to high-yield raspberry ketone synthesis provides 480 greater simplicity and lower cost. This method is scalable in vitro and potentially also 481 as a microbial fermentation route, potentially providing the most direct method for 482 obtaining industrial yields of raspberry ketone. 483 484 485
Raspberry ketone reductase activity utilises NADPH as a co-substrate which in 486 terms of scalable production is a costly co-factor. To further decrease the cost, we 487 relaxed the cofactor specificity of RKS enzyme to tolerate NADH. A number of 488 studies have highlighted that NADPH-dependent reductases can be engineered to 489 utilise the more stable and inexpensive NADH or biomimetic analogs 47-50 . As a 490 generalised approach, the structure-guided design of NAD(P)H enzymes can be 491 rationalised by altering the affinity for the ribose 5'-phosphate (NADPH) or hydroxyl 492 (NADH) group 51,52 . In the case of the RKS enzyme, position G191 provides flexible 493 control for engineering relaxed cofactor specificity. Its coupled use with an 494 inexpensive phosphate donor via the phosphite dehydrogenase 55 thus affords a low-495 cost route to raspberry ketone synthesis in vitro with NADH using any of the three 496 starting substrates described.
498
Approximately 80% of the fine chemical market that is used for cosmetics and food 499 additives, is currently produced by oil derived chemical synthesis and thus approved 500 for use if declared as "nature-identical" 59 . For fine chemicals that are extracted 501 naturally from food sources that require large agricultural landmasses, therefore, 502 potentially it is far simpler and more sustainable to engineer greener alternative 503 biocatalytic platforms, either from the use of engineered plants and microbes or 504 through in vitro isolated enzymes. Here, using raspberry ketone as a model pathway, 505
we have demonstrated how an apparently non-productive enzyme pathway can be 506 engineered to a high level of performance from outside of the cell. Essential to this 507 process is the ability to fine tune enzyme pathways in completion, rather than as 508 individual uncoupled kinetics, since shared resources (CoA, ATP) can impact overall 509 yields. In summary, synthetic biochemistry provides an expandable opportunity to 510 design synthetic enzyme ensembles in unison with cofactor availability. We have 511 applied this rational to optimise raspberry ketone, a small molecule that is not easily 512 obtained from within engineered living cells. Table  815 S2. 816 817
